Stroke Trial, Recruiting NCT06869811 Sponsor: Hospital Clinic of Barcelona Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06869811
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have had a stroke caused by a blood clot that traveled to the brain (linked to an irregular heart rhythm called atrial fibrillation), even while taking blood thinners, within the last 6 months.
  • You have a confirmed diagnosis of atrial fibrillation (AF) — any type.
  • The small pouch in your heart (called the left atrial appendage, or LAA) is suitable for a closure procedure (even if a clot is present in certain positions — confirm with trial site).
  • You are able to carry out daily activities without severe disability (your disability level must be below a certain threshold — confirm with trial site).
  • You are able to have a heart scan using CT or a special ultrasound (3D-TEE) with no medical reasons preventing this.
  • You are over 18 years old.
  • Your life expectancy is more than 1 year.
  • You are able to read and understand the consent form before joining the trial.
  • You are able and willing to attend follow-up visits and tests as required.

Who may not be able to join:

  • You have a medical reason that means you absolutely cannot take any blood thinners.
  • You missed more than a certain number of blood thinner doses in the week before your stroke (confirm with trial site for exact details).
  • Your stroke was a specific type called a "lacunar" stroke (a small stroke in a deep part of the brain).
  • You have a significant narrowing (more than 50%) of a major artery in your neck (carotid artery) that has been causing symptoms such as brief vision loss or mini-strokes on the same side.
  • You are scheduled for a heart operation or invasive procedure requiring sedation or anaesthesia within 3 months of joining the trial (not including procedures that are part of this study).
  • Your doctor considers you to be at high risk from general anaesthesia, and general anaesthesia is planned for your study procedure.
  • You have an untreated hole in the heart (called a patent foramen ovale, or PFO), or you already have a PFO closure device in place.
  • You have a filter placed in a large vein in your abdomen (inferior vena cava filter).
  • You have any condition that would normally prevent a catheter-based (thin tube through a blood vessel) procedure — for example, active infection or a bleeding disorder.
  • You have a condition that prevents a throat ultrasound (TEE) scan — for example, varicose veins in your oesophagus, a narrowed oesophagus, or a history of oesophageal cancer.
  • You had a catheter-based treatment for your irregular heart rhythm within the last 60 days.
  • You had a heart attack within the last 90 days.
  • You have very severe heart failure (the most advanced stage, known as New York Heart Association Class IV).
  • Your heart's pumping strength is very low (30% or less on your most recent test).
  • Your left atrial appendage has already been closed off or surgically tied shut.
  • You have a very low platelet count or severe anaemia that requires blood transfusions.
  • You are allergic to any materials used in the specific closure device being studied (for example, nickel allergy).
  • You are allergic to contrast dye used in CT scans, and you also cannot have a throat ultrasound (TEE) scan.
  • You are currently taking part in, or plan to join, another clinical trial whose treatment could affect the results of this study.
  • You are pregnant, breastfeeding, or planning to become pregnant during the study.
  • You have an active heart infection (endocarditis) or another infection that has spread to the bloodstream.
  • You have other medical, physical, social, or psychological conditions that, in your doctor's opinion, would prevent you from safely participating or completing the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Clinic of Barcelona
Registry
ClinicalTrials.gov
Start date
22 July 2024
Est. completion
22 February 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Primary Endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov